Bump- POH is the only Biotech anywhere to have delivered OxyM and OxyC via a transdermal patch. No other delivery tech has come close. So you just need to "stay alive" long enough to see some Phase 2 patch results - that's a given and it's not too far off. ... And then as you correctly point out - in the future there will likely be applications not even in the current POH Pipeline- that's the beauty of a platform technology
Update, page-55
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $408 | 154.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 90794613 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 54998583 | 13 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |